NASDAQ:WALD - JE00BPG99318 - Common Stock
The current stock price of WALD is 1.78 USD. In the past month the price increased by 10.56%. In the past year, price decreased by -49.43%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
UL | UNILEVER PLC-SPONSORED ADR | 24.45 | 157.68B | ||
KVUE | KENVUE INC | 17.4 | 35.73B | ||
EL | ESTEE LAUDER COMPANIES-CL A | 59.47 | 32.10B | ||
ELF | ELF BEAUTY INC | 42.13 | 7.60B | ||
BRBR | BELLRING BRANDS INC | 18.18 | 4.97B | ||
COTY | COTY INC-CL A | 19.86 | 3.81B | ||
IPAR | INTERPARFUMS INC | 22.09 | 3.63B | ||
ODD | ODDITY TECH LTD-CL A | 29.58 | 3.52B | ||
EPC | EDGEWELL PERSONAL CARE CO | 9.07 | 1.09B | ||
HLF | HERBALIFE LTD | 4.67 | 1.02B | ||
OLPX | OLAPLEX HOLDINGS INC | 18.63 | 993.95M | ||
YSG | YATSEN HOLDING LTD-ADR | N/A | 925.46M |
Waldencast Plc develops and operates a beauty and wellness platform by developing, acquiring, accelerating, and scaling the next generation of conscious, purpose-driven brands. The company is focused on developing, acquiring, accelerating, and scaling conscious and purpose-driven brands. Its segments include Obagi Medical and Milk Makeup. The Obagi Medical segment sells advanced skincare products backed by science and formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines and wrinkles, and to protect and enhance skin tone and texture. Its portfolio of medical-grade skincare with consumer-centric, in-office injectable procedures includes Saypha ChIQ, and MagIQ lines of injectable hyaluronic acid gels. The Milk Makeup segment consists of the business of Milk. Its Milk’s business activities include developing, marketing, and selling cosmetics, skincare, and other beauty products. Its Milk Makeup segment offers over 250 products through its United States Website www.MilkMakeup.com and retail partners include Sephora globally and Ulta Beauty in the United States.
WALDENCAST PLC-A
Michelin House, 81 Fulham Road
London NEW YORK GB
CEO: Michel Brousset
Employees: 332
Phone: 19175466828
The current stock price of WALD is 1.78 USD. The price increased by 11.95% in the last trading session.
The exchange symbol of WALDENCAST PLC-A is WALD and it is listed on the Nasdaq exchange.
WALD stock is listed on the Nasdaq exchange.
12 analysts have analysed WALD and the average price target is 3.57 USD. This implies a price increase of 100.56% is expected in the next year compared to the current price of 1.78. Check the WALDENCAST PLC-A stock analysts ratings, price target forecast and up-and down grades for more detailed information.
WALDENCAST PLC-A (WALD) has a market capitalization of 218.96M USD. This makes WALD a Micro Cap stock.
WALDENCAST PLC-A (WALD) currently has 332 employees.
WALDENCAST PLC-A (WALD) has a resistance level at 1.85. Check the full technical report for a detailed analysis of WALD support and resistance levels.
The Revenue of WALDENCAST PLC-A (WALD) is expected to grow by 8.78% in the next year. Check the estimates tab for more information on the WALD EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
WALD does not pay a dividend.
WALDENCAST PLC-A (WALD) will report earnings on 2025-11-11.
WALDENCAST PLC-A (WALD) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.39).
The outstanding short interest for WALDENCAST PLC-A (WALD) is 1.38% of its float. Check the ownership tab for more information on the WALD short interest.
ChartMill assigns a technical rating of 1 / 10 to WALD. When comparing the yearly performance of all stocks, WALD is a bad performer in the overall market: 94.93% of all stocks are doing better.
ChartMill assigns a fundamental rating of 2 / 10 to WALD. WALD has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months WALD reported a non-GAAP Earnings per Share(EPS) of -0.39. The EPS increased by 60.66% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -4.35% | ||
ROE | -6.41% | ||
Debt/Equity | 0.21 |
12 analysts have analysed WALD and the average price target is 3.57 USD. This implies a price increase of 100.56% is expected in the next year compared to the current price of 1.78.
For the next year, analysts expect an EPS growth of -103.96% and a revenue growth 8.78% for WALD